AI-powered home health technology company Enzo Health has raised $20 million in a Series A funding round.
The round, announced Monday, was led by N47 with participation from existing investors Gradient, Tandem Ventures and Rigby Watts. The cash infusion brings the company’s total funding to $26 million. The funds will be used to expand the platform’s home health offerings and diversify into the skilled nursing and hospice sectors.
“We’re investing heavily in expanding how much of the day-to-day work our platform can handle, so [home health] agencies no longer have to rely on a patchwork of disconnected tools,” Zach Newman, co-founder and CEO of Enzo Health, told Home Health Care News in an email. “By unifying intake, clinical documentation and [quality assurance] into a single platform, we reduce administrative overhead and eliminate redundant work across systems.”
Lehi, Utah-based Enzo operates an AI-powered technology platform that includes an intake tool, an AI scribe and a quality assurance tool built specifically for home health teams. The platform connects front-office, clinical and back-office operations.
Newman told HHCN that expanding into the hospice and skilled nursing sectors is the “natural extension of Enzo’s mission.”
“These settings face the same challenges we solve in home health: complex workflows, heavy documentation and regulatory pressure,” Newman said. “By bringing our AI-native platform across the continuum, we help providers operate more efficiently and deliver better, more coordinated patient care.”
Enzo, launched in 2024, increased its revenue more than 40-fold in its first 12 months, the company said. The platform is now used by organizations serving more than 500,000 patients each year.
“Enzo is redefining how home health organizations operate, removing the administrative burden that has long defined the industry and enabling clinicians and agencies to serve more patients,” Vivian Cheng, partner at N47, said in a statement. “By building an AI-native platform from the ground up, Enzo is enabling a level of automation and efficiency that legacy systems simply can’t match.”
Enzo is not the only AI-powered post-acute technology company to have raised funds in recent months. Carefam, an AI-powered health care human resources platform, recently raised $14.5 million. CareBestie, a home health technology company, and post-acute AI-enabled technology company Claim Health both raised $4.4 million this year.
The post Home Health Tech Company Enzo Health Raises $20M appeared first on Home Health Care News.
